Short communicationAn adult case of cerebral malakoplakia successfully cured by treatment with antibiotics, bethanechol (cas 111244-96-3) and ascorbic acid
-
Add time:09/03/2019 Source:sciencedirect.com
Cerebral malakoplakia is a very rare chronic inflammatory disease. We herein report the case of a 49-year-old female who presented with a slowly progressive speech disturbance and right hemiparesis. Computed tomography and magnetic resonance imaging showed irregular enhanced mass lesions with numerous scattered areas of calcification in the left insula, thalamus and basal ganglia. Histopathologically, the biopsy specimen showed basophilic laminated inclusion bodies and intracellular and extracellular calculospherules, usually with a typical targetoid appearance (Michaelis–Gutmann bodies). Treatment with antibiotics, bethanechol (cas 111244-96-3) and ascorbic acid improved her symptoms in association with a decrease in the abnormal calcification and enhancement. The cerebral malakoplakia mimicked a brain tumor in terms of the patient's clinical course and neuroradiological image findings; however, it was successfully cured with medical treatment. This case provides evidence that the pathogenesis of cerebral malakoplakia is deeply tied to bacterial infection and that medical treatment is effective in cases of this disease.
We also recommend Trading Suppliers and Manufacturers of bethanechol (cas 111244-96-3). Pls Click Website Link as below: cas 111244-96-3 suppliers
Prev:bethanechol (cas 111244-96-3)-induced responses in mudpuppy parasympathetic neurons
Next:In vitro effects of bethanechol (cas 111244-96-3) on smooth muscle preparations from abomasal fundus, corpus, and antrum of dairy cows) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- In vitro effects of bethanechol (cas 111244-96-3) on smooth muscle preparations from abomasal fundus, corpus, and antrum of dairy cows09/04/2019
- bethanechol (cas 111244-96-3)-induced responses in mudpuppy parasympathetic neurons09/02/2019
- INVESTIGATIVE UROLOGYELECTROMOTIVE ADMINISTRATION OF INTRAVESICAL bethanechol (cas 111244-96-3) AND THE CLINICAL IMPACT ON ACONTRACTILE DETRUSOR MANAGEMENT:: INTRODUCTION OF A NEW TEST09/01/2019
- Liver, Pancreas and Biliary Tractbethanechol (cas 111244-96-3) provocation testing does not predict symptom relief after cholecystectomy for acalculous biliary pain08/31/2019
- Bioengineering/NanomedicineIn vitro Effect of bethanechol (cas 111244-96-3) and Suberyldicholine on Regions of Guinea Pig Esophagus08/30/2019
- Phase III randomised trialDouble blind randomized prospective trial of bethanechol (cas 111244-96-3) in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients08/29/2019


